Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model

BACKGROUND: Influenza B virus infections remain insufficiently studied and antiviral management in immunocompromised patients is not well defined. The treatment regimens for these high-risk patients, which have elevated risk of severe disease-associated complications, require optimization and can be...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Antimicrob Chemother
Main Authors: Pascua, Philippe Noriel Q, Marathe, Bindumadhav M, Vogel, Peter, Webby, Richard J, Govorkova, Elena A
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477984/
https://ncbi.nlm.nih.gov/pubmed/30715325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dky560
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares